

According to a new review paper co-authored by two Johns Hopkins pain experts, scrambler therapy, a noninvasive pain treatment, can provide significant relief for approximately 80%-90% of chronic pain patients, and it may be more effective than another noninvasive therapy, transcutaneous electrical nerve stimulation (TENS). The study was published online in The New England Journal of Medicine on July 13.
Scrambler therapy, which was approved by the FDA in 2009, delivers electrical stimulation via the skin via electrodes inserted in parts of the body above and below where chronic pain is felt. According to Thomas Smith, M.D., the Harry J. Duffey Family Professor of Palliative Medicine at the Johns Hopkins Kimmel Cancer Center and a professor of oncology and medicine at the Johns Hopkins University School of Medicine, the goal is to capture the nerve endings and replace signals from the area experiencing pain with signals from adjacent areas experiencing no pain, thereby “scrambling” the pain signals sent to the brain.
According to Smith, who is also the director of palliative medicine at Johns Hopkins Medicine, all chronic pain and almost all nerve and neuropathic pain are caused by two things: pain impulses from damaged nerves that send a constant barrage up to pain centers in the brain, and the failure of inhibitory cells to block those impulses and prevent them from becoming chronic.
“If you can block the ascending pain impulses and enhance the inhibitory system, you can potentially reset the brain so it doesn’t feel chronic pain nearly as badly,” Smith says. “It’s like pressing Control-Alt-Delete about a billion times.”
Many patients “get really substantial relief that can often be permanent,” he says. They receive from three to 12 half-hour sessions.
As a physician who treats chronic pain, Smith says, “Scrambler therapy is the most exciting development I have seen in years — it’s effective, it’s noninvasive, it reduces opioid use substantially and it can be permanent.”
TENS therapy uses a pair of electrodes at the areas of discomfort to provide low-intensity electrical signals through the skin. According to Smith, pain alleviation frequently vanishes immediately or shortly after the electrical impulses are switched off. In a study included in the review report, the authors identified a nonstatistically significant difference in pain reduction between TENS and a placebo technique in 381 randomized clinical trials.
more recommended stories
Scientists Unveil Next-Gen Eye-Tracking with Unmatched Precision
Eye-tracking technology has long been a.
New Study Questions Fluid Restriction in Heart Failure Management
A groundbreaking study presented at the.
Role of Leptin Signaling in the DMH for Metabolic Regulation
A groundbreaking study from the Pennington.
COVID-19 Vaccines May Lower the Risk of Long COVID by 27%
A recent rapid review suggests that.
3D-Printed Hydrogel for Meniscus Tear Treatment
Meniscus tears are one of the.
Machine Learning Predicts Early Mortality in IBD Patients
A groundbreaking study published in the.
Endometriosis Treatment Advances: Latest Research and Therapy
Recent endometriosis treatment advances are reshaping.
Lung Cancer Screening Gaps Persist Despite Updated Guidelines
A recent study led by researchers.
Altered Knee Movement After ACL Surgery May Trigger Early Osteoarthritis
A recent study published in the.
BRP Peptide for Weight Loss: A Natural Alternative to Ozempic?
The rising obesity epidemic has fueled.
Leave a Comment